John Mavropoulos
MOHS-Micrographic Surgery · Orlando, FLNPI 1063737682
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,183 and has fallen 76.2% since, to $282 in 2025.
Across 109 payments — averaging $27.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$687
- Organogenesis Inc.$421
- Kerecis Limited$317
- LEO Pharma Inc.$315
- Regeneron Healthcare Solutions, Inc.$228
- Eli Lilly$175
- plus $887 from 19 others
Across 2 payments — averaging $4955.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$9K
- Argenx US, Inc.$1K
What the payments were for
- Consulting fees$2157%
- Food & beverage$2,81593%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $687 |
| Organogenesis Inc. | 18 | $421 |
| Kerecis Limited | 5 | $317 |
| LEO Pharma Inc. | 17 | $315 |
| Regeneron Healthcare Solutions, Inc. | 9 | $228 |
| Eli Lilly | 1 | $175 |
| Sun Pharmaceutical Industries Inc. | 7 | $146 |
| Lilly USA, LLC | 4 | $99 |
| Incyte Corporation | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $76 |
| Smith+Nephew | 2 | $67 |
| Boehringer Ingelheim | 2 | $53 |
| Johnson & Johnson | 3 | $52 |
| Galderma Laboratories, L.p. | 3 | $50 |
| Misonix Inc | 3 | $46 |
| Medtronic | 1 | $40 |
| EPI Health, LLC | 2 | $39 |
| Organon | 1 | $29 |
| Biofrontera Inc. | 1 | $21 |
| Pfizer | 1 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $16 |
| UCB, Inc. | 1 | $15 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
| Mimedx Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$611
- Kerecis Omega3 SurgiClose$204
- Kerecis Omega3 GraftGuide$204
- Skyrizi$109
- Rinvoq$108
- PuraPly$103
How this compares
$3,030 in reported general payments places this provider in the 65th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 66 | $815 |
| Doxycycline Monohydrate | 27 | $507 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Orlando
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.